Orthokeratology.

Night lens, day correction

Editors #PunktZwrotny2050 Sources checked: 09.09.2026 How to read this data

What is this method?

Orthokeratology uses carefully selected rigid lenses worn during sleep to temporarily change the shape of the anterior surface of the cornea. The effect on the rate of eye axis elongation was also examined.

Mechanism and idea

Changing the corneal profile corrects vision and changes the peripheral optical stimulus. The refractive effect is reversible; a shorter need to wear glasses during the day does not mean reversal of structural myopia.

How has the evidence developed?

ROMIO is one of the key RCTs. Current literature also includes combinations with low atropine concentrations and more recent studies of other combinations.

Go to full timeline

Key randomized trials

2012RCTHong Kong

Retardation of myopia in Orthokeratology (ROMIO) study: a 2-year randomized clinical trial

In ROMIO, the average axis gain was 0,36 mm in orthokeratology and 0,63 mm in the single vision group over 2 years.

78 children completed the study; unblinded users. Five people discontinued orthokeratology due to adverse events.

Publication, Authors and Restrictions
2026RCTSpain

Repeated low-level red-light therapy combined with orthokeratology for myopia control in Spain: a randomized controlled study

A Spanish RCT showed greater axis control when RLRL was added to orthokeratology than with orthokeratology alone.

Small, single-center and unblinded trial. This is a combination treatment study, not a European monotherapy RCT RLRL .

Publication, Authors and Restrictions

Evidence reviews and syntheses

The review is not a substitute for checking a specific intervention. The publication date and query end date may vary.

2025 Review/Consensus Global

IMI-Interventions for Controlling Myopia Onset and Progression 2025

IMI 2025 organizes optical, pharmacological, environmental and lighting strategies and the state of research on their effects.

Mature technologies and emerging methods have a different evidence base. The inspection is not an individual clinical eligibility assessment of the child.

Publication, Authors and Restrictions

What do longer observations tell us?

ROMIO provides a two-year comparison. Further decisions require inspection of the axis and cornea, also after discontinuation of wearing. Changing topography is not a substitute for measuring eye growth.

Safety

Nightwear requires strict hygiene, proper care and regular assessment of the cornea. Contact with water and improper handling increase the risk of infection. We do not use soft lens data to calculate the risk of orthokeratology.

Limitations and open questions

In ROMIO, some children did not complete the trial and five discontinued wearing due to adverse events. An RCT of this size does not accurately measure rare severe infections.

  • How to select lens geometry and evaluate response?
  • When does orthokeratology alone provide sufficient control?
  • How to safely switch to another strategy?

When is it considered?

It is sometimes considered after assessing the cornea, the defect, hygienic conditions and the possibility of inspection. The family's willingness to care for the lens is part of the clinical eligibility assessment.

What should be monitored?

  • Corneal topography, alignment and ocular surface
  • Axle length; the refraction itself after corneal modeling can be misleading
  • Care, symptoms and regularity of visits

This is a framework for a conversation with a specialist, not an individual treatment plan.

References for this chapter

2026Meta-analysis RCTGlobal

Efficacy and safety of low-concentration atropine combined with orthokeratology for children with myopia: a systematic review and meta-analysis of randomized controlled trials trials

A meta-analysis of RCTs showed additional inhibition of axis extension for low atropine with orthokeratology compared to orthokeratology alone.

Differences in observation times and protocols; collective benefit does not imply indication for every combination.

Publication, Authors and Restrictions
2021Guidelines/consensusEurope

Update and guidance on management of myopia. European Society of Ophthalmology in cooperation with International Myopia Institute

ESO and IMI present a framework for the selection of management, prevention and monitoring of myopia progression.

The guidelines require reference to current knowledge, local availability and the specific patient.

Publication, Authors and Restrictions

Availability

Text size
100%
Contrast
Reading
SOURCE RECORD

Source record